Cargando…
Human Antibodies that Slow Erythrocyte Invasion Potentiate Malaria-Neutralizing Antibodies
The Plasmodium falciparum reticulocyte-binding protein homolog 5 (PfRH5) is the leading target for next-generation vaccines against the disease-causing blood-stage of malaria. However, little is known about how human antibodies confer functional immunity against this antigen. We isolated a panel of...
Autores principales: | Alanine, Daniel G.W., Quinkert, Doris, Kumarasingha, Rasika, Mehmood, Shahid, Donnellan, Francesca R., Minkah, Nana K., Dadonaite, Bernadeta, Diouf, Ababacar, Galaway, Francis, Silk, Sarah E., Jamwal, Abhishek, Marshall, Jennifer M., Miura, Kazutoyo, Foquet, Lander, Elias, Sean C., Labbé, Geneviève M., Douglas, Alexander D., Jin, Jing, Payne, Ruth O., Illingworth, Joseph J., Pattinson, David J., Pulido, David, Williams, Barnabas G., de Jongh, Willem A., Wright, Gavin J., Kappe, Stefan H.I., Robinson, Carol V., Long, Carole A., Crabb, Brendan S., Gilson, Paul R., Higgins, Matthew K., Draper, Simon J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cell Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602525/ https://www.ncbi.nlm.nih.gov/pubmed/31204103 http://dx.doi.org/10.1016/j.cell.2019.05.025 |
Ejemplares similares
-
Antibodies from malaria-exposed Malians generally interact additively or synergistically with human vaccine-induced RH5 antibodies
por: Willcox, Alexandra C., et al.
Publicado: (2021) -
Heterotypic interactions drive antibody synergy against a malaria vaccine candidate
por: Ragotte, Robert J., et al.
Publicado: (2022) -
Assessment of precision in growth inhibition assay (GIA) using human anti-PfRH5 antibodies
por: Miura, Kazutoyo, et al.
Publicado: (2023) -
Functional Characterization and Comparison of Plasmodium falciparum Proteins as Targets of Transmission-blocking Antibodies
por: Nikolaeva, Daria, et al.
Publicado: (2020) -
Structure guided mimicry of an essential P. falciparum receptor-ligand complex enhances cross neutralizing antibodies
por: Srinivasan, Prakash, et al.
Publicado: (2023)